Agreed. Tend to place the RX Safe in the Mainstream and Retail.I would categorize other products RXSF has as Healthcare. I sort of understand why all the PR's are needed to keep RXSF PPS up and make a market, but as you say the Seasoned Healthcare Investor knows the risk and doesn't worry about the PPS. I don't totally agree with your Biotech analogy, as I see this more of a blend with healthcare, but fully understand what your saying.
How soon before RXSF concentrates on another product, or do we need funding first?
I am using this forum for it's original intention. It was created to discuss both points of view staying within the guidelines of the TOS. Remember where we are at all times. It is a DISCUSSION FORUM. Let's keep it real! This is not Trading floor on WALL